Tenofovir exerts antiviral effects in pregnant women with chronic hepatitis B by influencing the expression of <scp>miR</scp> ‐21‐5p
In pregnant women with CHB, TDF may inhibit HBV replication by inhibiting the expression of miR-21-5p. This mechanism contributes to the mitigation of infection exacerbation.
Authors
- Cuili Yang (ORCID: https://orcid.org/0000-0002-3524-8968)
- Lei Zhang (ORCID: https://orcid.org/0000-0002-0961-5795)
- Yu Wang (ORCID: https://orcid.org/0000-0001-6415-391X)
- Juan Du (ORCID: https://orcid.org/0000-0003-2642-551X)
- Zhongfu Mo
- Lan Shao
- Jinyu Gu
Publication Details
- Journal
- Journal of obstetrics and gynaecology research
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1111/jog.16355
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00